drugset / Trial / NCT02322957

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

NCT02322957

Phase 1 Completed 24 enrolled ContraVir Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to evaluate the potential for a PK drug-drug interaction between FV-100 and ritonavir. The study is a single-center, open-label, randomized, 2-way crossover design in healthy volunteers.

Timeline

Start
2015-02
Primary completion
2015-04
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject VALNIVUDINE Small molecule 400 mg

Indications